A Cost-Effectiveness Evaluation of Germline BRCA1 and BRCA2 Testing in UK Women With Ovarian Cancer

Value in Health - United Kingdom
doi 10.1016/j.jval.2017.01.004
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Novel Germline Mutations and Unclassified Variants of BRCA1 and BRCA2 Genes in Chinese Women With Familial Breast/Ovarian Cancer

BMC Cancer
Cancer ResearchOncologyGenetics
2016English

Cost-Effectiveness Analysis of Testing for Brca1 and Brca2 Mutations in Women Diagnosed With Ovarian Cancer and Their Female First- And Second Degree Relatives Using a Discrete Event Simulation: A Uk Health Service Perspective

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2015English

Management of Breast Cancer Risk in Women With Ovarian Cancer and Deleterious BRCA1 or BRCA2 Mutations

Annals of Surgical Oncology
OncologySurgery
2017English

Association Between BRCA1 and BRCA2 Mutations and Survival in Women With Invasive Epithelial Ovarian Cancer

JAMA - Journal of the American Medical Association
Medicine
2012English

Anti-Müllerian Hormone Serum Concentrations of Women With Germline BRCA1 or BRCA2 Mutations

Obstetrical and Gynecological Survey
MedicineGynecologyObstetrics
2016English

Germline BRCA1 and BRCA2 Deleterious Mutations and Variants of Unknown Clinical Significance Associated With Breast/Ovarian Cancer: A Report From North India

Cancer Management and Research
Oncology
2018English

The Germline Mutational Landscape of BRCA1 and BRCA2 in Brazil

Scientific Reports
Multidisciplinary
2018English

Pcn195 - Cost-Utility Analysis of the Germline Brca Testing in Women With Epithelial Ovarian Cancer Without Family History in Spain

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Cost-Effectiveness Analysis of Reflex Testing for Lynch Syndrome in Women With Endometrial Cancer in the UK Setting

PLoS ONE
Multidisciplinary
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy